Aaron Cowen’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
Other funds holding CLDX
KCM
BBA
Aaron Cowen's CLDX Position: Q3 2026 in Review
Aaron Cowen held its Celldex Therapeutics (CLDX) position steady in Q3 2026 at 121,297 shares worth $3.93M. The position accounts for 0.09% of the portfolio, ranked #61.
Aaron Cowen first reported a position in CLDX in Q2 2026 and has held it in 2 quarters since. The position peaked at $4.51M in Q2 2026. 249 funds tracked by Wall St. Rank hold CLDX as of Q3 2026.
- Aaron Cowen held 121,297 shares of Celldex Therapeutics worth $3.93M as of Q3 2026.
- Aaron Cowen left its Celldex Therapeutics share count unchanged in Q3 2026.
- Celldex Therapeutics made up 0.09% of Aaron Cowen's portfolio in Q3 2026, its #61 holding.
- Aaron Cowen first reported a position in Celldex Therapeutics in Q2 2026 and has held it in 2 quarters since.
- Aaron Cowen's Celldex Therapeutics position peaked at $4.51M in Q2 2026.
- 249 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2026.
Based on Suvretta Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.